
Man fired 180 shots, breaking 150 windows, in CDC attack
It may take weeks or even months to replace windows and clean up the damage, Centers for Disease Control and Prevention personnel said.
A Georgia man who had blamed the COVID-19 vaccine for making him depressed and suicidal opened fire late Friday, killing a police officer. No one at CDC was injured.
The shooter was stopped by CDC security guards before driving to a nearby pharmacy and opening fire late Friday afternoon, a law enforcement official has told the AP. The official wasn't authorized to publicly discuss the investigation and spoke on condition of anonymity. The 30-year-old man, Patrick Joseph White, later died, but authorities haven't said whether he was killed by police or killed himself.
Health Secretary Robert F. Kennedy Jr. toured the CDC campus on Monday. CDC security pointed out broken windows across buildings, including the main guard booth, according to a Department of Health and Human Services statement.
HHS Deputy Secretary Jim O'Neill and CDC Director Susan Monarez accompanied him, according to the statement.
Kennedy also visited the DeKalb County Police Department, where he met with the police chief. Later. He also met privately with the widow of the fallen officer, David Rose.
Monarez posted a statement on social media Friday night that said at least four CDC buildings were hit in the attack.
The extent of the damage became more clear during a weekend CDC leadership meeting. Two CDC employees who were told about what was discussed at the meeting described details to The Associated Press on condition of anonymity because they weren't authorized to reveal the information. Details also were also in an agency memo seen by an AP reporter.
Building 21, which houses Monarez's office, was hit by the largest number of bullets. CDC officials did not say if her office was hit.
CDC employees were advised to work from home this week.
'No one should face violence while working to protect the health of others,' Kennedy said in a Saturday statement, adding top federal health officials were 'actively supporting CDC staff.'
He did not speak to the media during his visit Monday.
In a call with the media on Monday night, some unionized CDC employees said they are calling for more heavily armed guards, bulletproof glass, a better alert system and more extensive evacuation planning for disabled employees and other vulnerable staff.
A retired CDC official, Stephan Monroe, said he worried about the long-term impact the attack would have on young scientists' willingness to go to work for the government.
'I'm concerned that this is this is going to be a generational hit,' said Monroe, speaking to a reporter near the corner where a poster had been set up in honor of Rose.
Kennedy was a leader in a national anti-vaccine movement before President Donald Trump selected him to oversee federal health agencies and has made false and misleading statements about the safety and effectiveness of about COVID-19 shots and other vaccines.
Years of false rhetoric about vaccines and public health was bound to 'take a toll on people's mental health,' and 'leads to violence,' said Tim Young, a CDC employee who retired in April.
Dr. Jerome Adams, the US surgeon general during Trump's first administration, said Sunday that health leaders should appreciate the weight of their words.
'We have to understand people are listening,' Adams told 'Face the Nation' on CBS. 'When you make claims that have been proven false time and time again about safety and efficacy of vaccines, that can cause unintended consequences.'
CDC employees are now taking steps to become less visible, including not wearing their public health service uniform to work, said Yolanda Jacobs, president of Local 2883 of the American Federation of Government Employees.
She recalled when CDC employees were happy to be approached by neighbors or others with public health questions. 'Now, it's at the point we're afraid to have those types of conversations with anybody, because we don't know who they are and we don't know what rhetoric they've ingested,' she said.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Edwards Lifesciences Stock: Analyst Estimates & Ratings
With a market cap of $45.2 billion, Edwards Lifesciences Corporation (EW) is a global leader in innovative products and technologies for treating advanced cardiovascular diseases. The company specializes in transcatheter and surgical heart valve solutions, as well as critical care monitoring systems, serving patients across the United States, Europe, Japan, and worldwide. Shares of the Irvine, California-based company have underperformed the broader market over the past 52 weeks. EW stock has increased 17.1% over this time frame, while the broader S&P 500 Index ($SPX) has gained 18.7%. Moreover, shares of the company have risen 4.9% on a YTD basis, compared to SPX's 9.7% return. More News from Barchart Warren Buffett Warns Investing At 'Too-High Purchase Price' Even for 'an Excellent Company' Can Undo a Decade of Smart Investing BitMine Immersion Now Holds 1.15 Million Ethereum Tokens. Should You Buy BMNR Stock Here? Why Archer Aviation's (ACHR) Post-Earnings Tailspin Looks Like a Favorably Mispriced Opportunity Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Looking closer, Edwards Lifesciences stock has outpaced the Health Care Select Sector SPDR Fund's (XLV) 12.1% decrease over the past 52 weeks. Shares of Edwards Lifesciences rose 5.5% following its Q2 2025 results on Jul. 24, with adjusted EPS of $0.67 and sales of $1.5 billion, both exceeding estimates and showing strong year-over-year growth. Segment strength was led by TAVR sales of $1.1 billion, TMTT sales of $134.5 million, and Surgical Structural Heart sales of $267 million. The company also raised its 2025 sales growth guidance to $5.90 billion - $6.10 billion and projected adjusted EPS at the high end of $2.40 - $2.50. For the fiscal year ending in December 2025, analysts expect EW's adjusted EPS to grow 2.9% year-over-year to $2.50. The company's earnings surprise history is promising. It topped or met the consensus estimates in the last four quarters. Among the 30 analysts covering the stock, the consensus rating is a 'Moderate Buy.' That's based on 15 'Strong Buy' ratings, one 'Moderate Buy,' 13 'Holds,' and one 'Strong Sell.' This configuration is more bullish than three months ago, with 12 'Strong Buy' ratings on the stock. On Jul. 25, RBC Capital raised its price target on Edwards Lifesciences to $89 with an 'Outperform' rating. As of writing, the stock is trading below the mean price target of $87.28. The Street-high price target of $101 implies a modest potential upside of 30% from the current price levels. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on


New York Times
42 minutes ago
- New York Times
The Best Medicine of All Was Each Other
Spoiler alert: They're fine. Kimberly Blair Hoffman likes to recall a lighter, sunnier side of the moment when Joshua Craig Woda reached out to her in October 2021, after seven and a half years. He messaged her on Facebook, despite already having her phone number. 'This is always a point she finds funny,' said Mr. Woda, 31, then on the verge of a bone-marrow transplant after a relapse of Hodgkin lymphoma, a type of cancer that affects the lymphatic system. He knew she would know exactly what he was going through. She already had two transplants herself. Each had first been diagnosed while they were students at Binghamton University. The two had met briefly, and awkwardly, in March 2014 when he was a sophomore and she a senior. His fraternity and her sorority had organized a dodgeball tournament, with them in mind — Dodgekins Lymphoma, a fund-raiser for the Leukemia and Lymphoma Society. They were both in remission at the time. Ms. Hoffman said that they 'exchanged stories, symptoms and diagnoses,' via email and text before the event. She had a stem cell transplant the previous January, and although she took the semester off, she felt well enough most weekends to drive from her parents' home in Brooklyn to visit her off-campus house. He had just finished eight rounds of chemotherapy while taking classes and living on campus. 'Aside from both being in other relationships,' she said, 'we were too young and too naïve going through this. How do you have a normal conversation?' Want all of The Times? Subscribe.
Yahoo
43 minutes ago
- Yahoo
Federal judge blocks Trump administration's broad birth control mandate exemptions
The Trump administration's religious and moral carve-outs to an ObamaCare requirement that all employer health plans cover contraception at no cost were blocked on Wednesday by a federal judge. District Judge Wendy Beetlestone in Philadelphia issued a summary judgment that the rules were arbitrary, capricious and an overreach of the authority of the agencies that wrote them in 2017. Under the rules, essentially any for-profit or nonprofit employer or insurer was allowed to exempt themselves from following the birth control mandate on moral and religious grounds. The rules also let publicly traded companies obtain a religious exemption, but not a moral one. The Affordable Care Act required employer health plans to cover at least one of 18 forms of birth control approved by the Food and Drug Administration. Religious groups and employers sued, and the Supreme Court in 2014 ruled 5-4 that the contraceptive mandate violated the Religious Freedom Restoration Act (RFRA) rights of closely held corporations whose owners had religious objections. Subsequent agency actions tried to find a balance, but the Trump administration in 2017 issued a blanket exemption. The rules didn't require employers to apply for an exemption because the administration said that would be a violation of their religious rights. Pennsylvania, New Jersey and dozens of other states sued to halt that broad expansion of exemptions and accommodations. That lawsuit reached the Supreme Court in 2020, where the justices upheld the Trump rules on technical grounds but did not address the underlying merits of the case. The case was sent back to the lower court, where a religious group, Little Sisters of the Poor, joined the lawsuit alongside the federal government in asking for summary judgment. Beetlestone, an appointee of former President Obama, wrote that the Trump administration's religious rule did not accomplish what the agencies purportedly wrote it to do, which was to resolve a conflict between the contraceptive mandate and RFRA. But the rule exemptions to organizations that are 'unlikely, if ever, to be capable of maintaining a religious objection, raising further doubts as to any 'rational connection' between the Rule and remedying potential conflicts with RFRA,' Beetlestone wrote. The Little Sisters of the Poor will appeal the ruling in the coming weeks, according to the Becket Fund for Religious Liberty, a nonprofit that represents the order. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.